To characterize patients with positive anti-topoisomerase I (ATA) in the limited cutaneous Systemic Sclerosis (lcSSc).

Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort

Carlo Francesco Selmi
Membro del Collaboration Group
;
2022-01-01

Abstract

To characterize patients with positive anti-topoisomerase I (ATA) in the limited cutaneous Systemic Sclerosis (lcSSc).
2022
Scleroderma
Systemic sclerosis
anti-topoisomerase I
cutaneous form
disease subset
interstitial lung disease
outcome
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/78323
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 22
social impact